Patent ID: 8349865
Filing Date: 2013-01-08
Classification: A61P,C07D

Abstract:
1. A compound of the formula I: wherein D is CR E is N or CR G is CR J is CR L is —NH —; M is (a) hydrogen, (b) halo, (c) hydroxyl, (d) C (e) C (f) C (g) C (h) (C (i) aryl, which is optionally substituted with one to four substituents independently selected from the group consisting of halo, hydroxyl, cyano, C (j) heteroaryl, which optionally substituted on either the carbon or heteroatom with one to three substituents independently selected from the group consisting of halo, oxo, aryl and R (k) heterocyclyl, (l) (C (m) C(O)R (n) NR R R R R R R R R m is an integer from zero to two; or a pharmaceutically acceptable salt or stereoisomer thereof.